Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-09-23
1991-02-19
Fan, Jane T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514336, 5142228, 5142238, 5142315, 546321, 546284, 544131, C07D21186, A61K 31455
Patent
active
049944762
ABSTRACT:
A series of compounds useful in treating cardiovascular disorders due to the combined expression of both .beta.-block and calcium-block activity by these agents. This useful combination of actions is effected by a novel combination of structural subunits forming these compounds. Essentially, .beta.-blocking aryloxypropanolamine moieties are attached via their aryl ring or amino nitrogen at one of the carboxylate groups of calcium-blocking 4-aryl-1,4-dihydropyridine-3,5-dicarboxylates. These compounds are prepared from new 4-aryl-1,4-dihydropyridine intermediate compounds.
REFERENCES:
patent: 3485847 (1969-12-01), Bossert et al.
patent: 4532248 (1985-07-01), Franckowink et al.
Baldwin et al., J. Med. Chem., 24, pp. 628-631 (1981).
Bossert, F. et al., "4-Aryldihydropyridine", Angew. Chem. Int. Ed. Engl. 20, (1981), pp. 762-769.
Bristol-Myers Company
Fan Jane T.
Uloth Robert H.
LandOfFree
Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanola does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanola, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanola will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1143953